日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial

沙库巴曲/缬沙坦预防乳腺癌辅助治疗期间心脏功能障碍:PRADA II 随机临床试验

Omland, Torbjørn; Heck, Siri Lagethon; Holte, Espen; Lilleaasen, Albulena Mecinaj; Gynnild, Mari Nordbø; Fagerland, Morten Wang; Vinje-Jakobsen, Victoria; Næs, Anne-Katrine Lislegaard; Blix, Egil Støre; Larsen, Alf Inge; Geisler, Jürgen; Gulati, Geeta; Wethal, Torgeir

The SARAH trial: more evidence on the role of neurohormonal blockers in prevention of anthracycline-induced cardiotoxicity

SARAH试验:神经激素阻滞剂在预防蒽环类药物引起的心脏毒性方面的作用的更多证据

Mecinaj, Albulena; Vinje-Jakobsen, Victoria; Ngo, Doan T M; Sverdlov, Aaron L; Myhre, Peder L

Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac Dysfunction

ESC心脏肿瘤指南生物标志物标准对癌症治疗相关心脏功能障碍发生率的影响

Mecinaj, Albulena; Gulati, Geeta; Ree, Anne Hansen; Gravdehaug, Berit; Røsjø, Helge; Steine, Kjetil; Wisløff, Torbjørn; Geisler, Jürgen; Omland, Torbjørn; Heck, Siri Lagethon

Reply: Probing the Anthracycline-Induced Myocardial Injury: A Glimpse Through the Lens of the PRADA Trial

回复:探究蒽环类药物引起的心肌损伤:从PRADA试验的视角看问题

Mecinaj, Albulena; Gulati, Geeta; Omland, Torbjørn; Heck, Siri Lagethon

Trajectory of cardiac troponin T following moderate-to-severe COVID-19 and the association with cardiac abnormalities

中重度 COVID-19 后心肌肌钙蛋白 T 的变化轨迹及其与心脏异常的关系

Øvrebotten, Tarjei; Mecinaj, Albulena; Stavem, Knut; Ghanima, Waleed; Brønstad, Eivind; Durheim, Michael T; Lerum, Tøri V; Josefsen, Tony; Grimsmo, Jostein; Heck, Siri L; Omland, Torbjørn; Ingul, Charlotte B; Einvik, Gunnar; Myhre, Peder L

Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19

新冠肺炎住院治疗3个月后出现心脏功能障碍和心律失常

Ingul, Charlotte B; Grimsmo, Jostein; Mecinaj, Albulena; Trebinjac, Divna; Berger Nossen, Magnus; Andrup, Simon; Grenne, Bjørnar; Dalen, Håvard; Einvik, Gunnar; Stavem, Knut; Follestad, Turid; Josefsen, Tony; Omland, Torbjørn; Jensen, Torstein

Changes in cardiac structure and function from 3 to 12 months after hospitalization for COVID-19

新冠肺炎住院治疗后3至12个月心脏结构和功能的变化

Øvrebotten, Tarjei; Myhre, Peder; Grimsmo, Jostein; Mecinaj, Albulena; Trebinjac, Divna; Nossen, Magnus B; Andrup, Simon; Josefsen, Tony; Einvik, Gunnar; Stavem, Knut; Omland, Torbjørn; Ingul, Charlotte B

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol

预防乳腺癌辅助治疗期间心脏功能障碍(PRADA):坎地沙坦和美托洛尔2×2析因随机安慰剂对照双盲临床试验的延长随访

Heck, Siri Lagethon; Mecinaj, Albulena; Ree, Anne Hansen; Hoffmann, Pavel; Schulz-Menger, Jeanette; Fagerland, Morten Wang; Gravdehaug, Berit; Røsjø, Helge; Steine, Kjetil; Geisler, Jürgen; Gulati, Geeta; Omland, Torbjørn

Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial

预防乳腺癌辅助治疗期间心脏功能障碍(PRADA II)试验的原理和设计:一项随机、安慰剂对照、多中心试验

Mecinaj, A; Gulati, G; Heck, S L; Holte, E; Fagerland, M W; Larsen, A I; Blix, E S; Geisler, J; Wethal, T; Omland, T

Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity

新冠肺炎住院6个月后出现的心脏病理学改变及其与急性期疾病严重程度的关联

Myhre, Peder L; Heck, Siri L; Skranes, Julia B; Prebensen, Christian; Jonassen, Christine M; Berge, Trygve; Mecinaj, Albulena; Melles, Woldegabriel; Einvik, Gunnar; Ingul, Charlotte B; Tveit, Arnljot; Berdal, Jan Erik; Røsjø, Helge; Lyngbakken, Magnus N; Omland, Torbjørn